ASSET | QUARTER | % RETURN |
---|---|---|
Teekay Tankers (TNK) | Q4 2019 | 1,743.82% |
Pennant (PNTG) | Q4 2019 | 437.72% |
Kodiak Sciences (KOD) | Q4 2019 | 400.35% |
Neurogene (NGNE) | Q4 2019 | 323.37% |
Aurinia Pharmaceuticals (AUPH) | Q4 2019 | 277.28% |
Nordic American Tankers (NAT) | Q4 2019 | 126.99% |
Progyny (PGNY) | Q4 2019 | 103.33% |
BW LPG (BWLP) | Q4 2019 | 102.14% |
Prothena (PRTA) | Q4 2019 | 101.91% |
Rocket Pharmaceuticals (RCKT) | Q4 2019 | 95.87% |
Castle Biosciences (CSTL) | Q4 2019 | 89.58% |
Arvinas (ARVN) | Q4 2019 | 88.49% |
Centrus Energy (LEU) | Q4 2019 | 86.45% |
Arbutus Biopharma (ABUS) | Q4 2019 | 85.33% |
Uniqure (QURE) | Q4 2019 | 83.74% |
InMode (INMD) | Q4 2019 | 82.92% |
Zymeworks Inc Common Stock (ZYME) | Q4 2019 | 82.79% |
Avadel Pharmaceuticals (AVDL) | Q4 2019 | 81.93% |
Corvus Pharmaceuticals (CRVS) | Q4 2019 | 79.54% |
Borr Drilling (BORR) | Q4 2019 | 79.21% |
Collegium Pharmaceutical (COLL) | Q4 2019 | 78.8% |
Eastman Kodak (KODK) | Q4 2019 | 74.16% |
Cango (CANG) | Q4 2019 | 73.85% |
Central Puerto (CEPU) | Q4 2019 | 70.34% |
Savara (SVRA) | Q4 2019 | 69.7% |